{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:24:30Z","timestamp":1790011470031,"version":"4.0.1"},"reference-count":143,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Y004094\/1"],"award-info":[{"award-number":["MR\/Y004094\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union's Horizon Europe Research and Innovation Programme","award":["Psych-STRATA project under grant agreement No. 101057454"],"award-info":[{"award-number":["Psych-STRATA project under grant agreement No. 101057454"]}]},{"name":"European Union\u00e2\u20ac\u2122s Horizon 2020 research and innovation programme","award":["REALMENT project under grant agreement No. 964874"],"award-info":[{"award-number":["REALMENT project under grant agreement No. 964874"]}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH124873"],"award-info":[{"award-number":["R01MH124873"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Despite significant progress in understanding the genetic basis of schizophrenia, there is a clear gap in our understanding of the genetics of outcomes in schizophrenia, particularly those prioritised by people with the condition. This has impeded progress towards precision psychiatry for schizophrenia and the improvement of outcomes. As genomic cohorts continue to increase in number, size, diversity, and phenotypic detail, sufficient data are now available to enable within-case studies focusing on the genetic basis of outcomes in schizophrenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The GENios programme of research will use existing and new data to undertake large-scale genomic studies of schizophrenia outcomes. The project focuses on four key outcomes that were prioritised for research by individuals with lived experience of schizophrenia and align with priorities identified in the literature: antipsychotic treatment response; hospital admissions; occupational functioning; and social functioning. The aims of this project are to understand the genetic contributions to these outcomes in schizophrenia to (i) advance current understanding of the biological mechanisms that drive variability in outcomes, (ii) highlight novel drug targets, and (iii) identify genomic predictors of outcomes that can be leveraged for precision medicine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The GENios project has been granted ethical approval and collaborators are required to have the appropriate ethical permission in place to contribute data to the project. Findings from this study will be interpreted and disseminated with the involvement of lived experience experts in scientific publications and conferences as well as to wider non-scientific communities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Plain English summary<\/jats:title>\n                    <jats:p>Schizophrenia is a severe mental illness that affects how people think, feel, and behave. Whilst current treatments help with some symptoms and effects of the disorder, many people continue to struggle with poor long-term outcomes. Outcomes like repeated hospital stays, difficulties with socialising and relationships, and difficulties with finding and maintaining employment. People with lived experience of schizophrenia have identified some outcomes as research priorities. These research priorities are treatment response, hospital admissions, day-to-day living (e.g. having a job), and having relationships.<\/jats:p>\n                    <jats:p>Many people with schizophrenia are given antipsychotic medications to treat \u2018positive\u2019 symptoms (such as unusual (false or disturbing) thoughts and beliefs, and seeing and hearing things that are not there). These medications work for some people but around 25% to 30% of people with the disorder have symptoms that are not helped by standard antipsychotic treatments. These symptoms are classed as treatment-resistant. Many more people find that antipsychotic medications do not help with \u2018negative\u2019 symptoms (such as feeling emotionally blank and having trouble with motivation) and difficulty with cognitive abilities (such as concentrating, planning, and memory).<\/jats:p>\n                    <jats:p>This project, called GENios, aims to understand why outcomes differ between people with schizophrenia by looking at their genetics. We understand that social factors play an important role in outcomes but this project is specifically focused on genetics. We will analyse data from people with schizophrenia with an aim to uncover the genetic factors that influence outcomes by using data has already been collected by other research projects. We are carrying out this research in order to identify how genes and knowledge of people\u2019s genetics can help develop healthcare that is more tailored to an individual, so-called precision psychiatry. A plain English glossary of terms is included (S1 Table) to help explain technical language used in the main text.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0340584","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:36:03Z","timestamp":1770316563000},"page":"e0340584","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetics to Improve Outcomes in Schizophrenia (GENios): A within-case molecular genetic study protocol"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6709-5425","authenticated-orcid":true,"given":"Sophie E.","family":"Smart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6946-5768","authenticated-orcid":true,"given":"Eilidh","family":"Fenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhys","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6893-7022","authenticated-orcid":true,"given":"Katherine","family":"Fender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bresner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Trauzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella R.","family":"Willcocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie E.","family":"Legge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio F.","family":"Pardi\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Escott-Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Holmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"O\u2019Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T. R.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"pone.0340584.ref001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/epirev\/mxn001","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality","volume":"30","author":"J McGrath","year":"2008","journal-title":"Epidemiol Rev"},{"issue":"12","key":"pone.0340584.ref002","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","article-title":"Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019","volume":"28","author":"M Solmi","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"7906","key":"pone.0340584.ref003","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","article-title":"Mapping genomic loci implicates genes and synaptic biology in schizophrenia","volume":"604","author":"V Trubetskoy","year":"2022","journal-title":"Nature"},{"issue":"7906","key":"pone.0340584.ref004","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-022-04556-w","article-title":"Rare coding variants in ten genes confer substantial risk for schizophrenia","volume":"604","author":"T Singh","year":"2022","journal-title":"Nature"},{"issue":"1","key":"pone.0340584.ref005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.biopsych.2020.01.017","article-title":"Large-scale genomics: a paradigm shift in psychiatry?","volume":"89","author":"MJ Owen","year":"2021","journal-title":"Biol Psychiatry"},{"issue":"6","key":"pone.0340584.ref006","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/schbul\/sbs130","article-title":"A systematic review and meta-analysis of recovery in schizophrenia","volume":"39","author":"E J\u00e4\u00e4skel\u00e4inen","year":"2013","journal-title":"Schizophr Bull"},{"issue":"7","key":"pone.0340584.ref007","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13094","article-title":"Very long-term outcome of schizophrenia","volume":"72","author":"J Volavka","year":"2018","journal-title":"Int J Clin Pract"},{"issue":"9","key":"pone.0340584.ref008","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.euroneuro.2017.06.011","article-title":"How well do patients with a first episode of schizophrenia respond to antipsychotics: A systematic review and meta-analysis","volume":"27","author":"Y Zhu","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"pone.0340584.ref009","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.2017.16121358","article-title":"Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors","volume":"174","author":"S Leucht","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"9","key":"pone.0340584.ref010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"J Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"pone.0340584.ref011","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1192\/bjp.2021.61","article-title":"Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis","volume":"220","author":"D Siskind","year":"2022","journal-title":"Br J Psychiatry"},{"issue":"4","key":"pone.0340584.ref012","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","article-title":"Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis","volume":"4","author":"C Hjorth\u00f8j","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"pone.0340584.ref013","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.schres.2018.04.009","article-title":"Premature mortality among people with severe mental illness - New evidence from linked primary care data","volume":"199","author":"A John","year":"2018","journal-title":"Schizophr Res"},{"key":"pone.0340584.ref014","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4088\/JCP.14074su1c.02","article-title":"Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia","author":"MF Green","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"pone.0340584.ref015","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.schres.2022.04.002","article-title":"A meta-analysis of social cognitive deficits in schizophrenia: Does world region matter?","volume":"243","author":"S Weinreb","year":"2022","journal-title":"Schizophr Res"},{"issue":"7","key":"pone.0340584.ref016","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF00788182","article-title":"Outcome of marriage in schizophrenia","volume":"32","author":"R Thara","year":"1997","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"1","key":"pone.0340584.ref017","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/acps.13254","article-title":"Employment among people with schizophrenia or bipolar disorder: A population-based study using nationwide registers","volume":"143","author":"M Holm","year":"2021","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"pone.0340584.ref018","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/jamapsychiatry.2013.268","article-title":"Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings","volume":"70","author":"RA Power","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"pone.0340584.ref019","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12916-016-0734-z","article-title":"Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries","volume":"14","author":"B Stubbs","year":"2016","journal-title":"BMC Med"},{"issue":"5","key":"pone.0340584.ref020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11920-024-01500-9","article-title":"Multimorbidity and the Etiology of Schizophrenia","volume":"26","author":"A Szoke","year":"2024","journal-title":"Curr Psychiatry Rep"},{"issue":"9","key":"pone.0340584.ref021","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s40273-017-0515-3","article-title":"The Cost of Relapse in Schizophrenia","volume":"35","author":"M Pennington","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"pone.0340584.ref022","first-page":"91","article-title":"Measuring psychosocial outcomes in schizophrenia patients","volume":"24","author":"ML Figueira","year":"2011","journal-title":"Curr Opin Psychiatry"},{"key":"pone.0340584.ref023","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-030-19847-3_10","article-title":"Outcome measurement in schizophrenia: Challenges and barriers.","volume-title":"Schizophrenia treatment outcomes: An evidence-based approach to recovery","author":"S Grover","year":"2020"},{"issue":"13","key":"pone.0340584.ref024","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1017\/S0033291714001378","article-title":"The onset and offset of psychosis--and what happens in between--a commentary on \u2018Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 Study\u2019 by Morgan et al. (2014)","volume":"44","author":"JJ McGrath","year":"2014","journal-title":"Psychol Med"},{"key":"pone.0340584.ref025","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.schres.2022.11.010","article-title":"The prognosis of schizophrenia: A systematic review and meta-analysis with meta-regression of 20-year follow-up studies","volume":"250","author":"I-M Molstrom","year":"2022","journal-title":"Schizophr Res"},{"issue":"3","key":"pone.0340584.ref026","doi-asserted-by":"crossref","first-page":"393","DOI":"10.31887\/DCNS.2010.12.3\/mlambert","article-title":"Remission in schizophrenia: validity, frequency, predictors, and patients\u2019 perspective 5 years later","volume":"12","author":"M Lambert","year":"2010","journal-title":"Dialogues Clin Neurosci"},{"issue":"4","key":"pone.0340584.ref027","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ajp.2010.09.004","article-title":"Health outcomes of schizophrenia in Thailand: Health care provider and patient perspectives","volume":"3","author":"P Phanthunane","year":"2010","journal-title":"Asian J Psychiatr"},{"issue":"1","key":"pone.0340584.ref028","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12888-017-1418-8","article-title":"Treatment outcomes in schizophrenia: qualitative study of the views of family carers","volume":"17","author":"J Lloyd","year":"2017","journal-title":"BMC Psychiatry"},{"issue":"4","key":"pone.0340584.ref029","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/schbul\/sbw146","article-title":"Heritability of Neuropsychological Measures in Schizophrenia and Nonpsychiatric Populations: A Systematic Review and Meta-analysis","volume":"43","author":"GAM Blokland","year":"2017","journal-title":"Schizophr Bull"},{"issue":"10","key":"pone.0340584.ref030","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jamapsychiatry.2021.1961","article-title":"Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia","volume":"78","author":"SE Legge","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"pone.0340584.ref031","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.schres.2008.01.023","article-title":"The genetics of symptom dimensions of schizophrenia: review and meta-analysis","volume":"102","author":"T Rietkerk","year":"2008","journal-title":"Schizophr Res"},{"issue":"10","key":"pone.0340584.ref032","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamapsychiatry.2022.2289","article-title":"Ultrarare Coding Variants and Cognitive Function in Schizophrenia","volume":"79","author":"HDJ Creeth","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"pone.0340584.ref033","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.biopsych.2020.11.025","article-title":"Rare copy number variants are associated with poorer cognition in schizophrenia","volume":"90","author":"L Hubbard","year":"2021","journal-title":"Biol Psychiatry"},{"issue":"1","key":"pone.0340584.ref034","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/15622975.2021.1907722","article-title":"Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia","volume":"23","author":"M Gennarelli","year":"2022","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"pone.0340584.ref035","doi-asserted-by":"crossref","first-page":"10179","DOI":"10.1038\/s41598-021-89540-6","article-title":"Prediction of functional outcomes of schizophrenia with genetic biomarkers using a bagging ensemble machine learning method with feature selection","volume":"11","author":"E Lin","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0340584.ref036","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/acps.13444","article-title":"Association between psychiatric hospitalizations of patients with schizophrenia and polygenic risk scores based on genes with altered expression by antipsychotics","volume":"146","author":"F Facal","year":"2022","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"pone.0340584.ref037","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/mp.2015.130","article-title":"High loading of polygenic risk in cases with chronic schizophrenia","volume":"21","author":"SM Meier","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"3","key":"pone.0340584.ref038","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamapsychiatry.2021.3799","article-title":"Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia","volume":"79","author":"AF Pardi\u00f1as","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"pone.0340584.ref039","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41380-021-01387-5","article-title":"Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants","volume":"27","author":"R Zhang","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"9","key":"pone.0340584.ref040","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1038\/s41380-024-02516-6","article-title":"Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders","volume":"29","author":"A K\u00e4mpe","year":"2024","journal-title":"Mol Psychiatry"},{"issue":"7","key":"pone.0340584.ref041","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.20230073","article-title":"Association of Occupational Dysfunction and Hospital Admissions With Different Polygenic Profiles in Bipolar Disorder","volume":"181","author":"L Jonsson","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"13","key":"pone.0340584.ref042","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1017\/S0033291720005334","article-title":"Genetic architecture of schizophrenia: a review of major advancements","volume":"51","author":"SE Legge","year":"2021","journal-title":"Psychol Med"},{"issue":"7","key":"pone.0340584.ref043","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/mp.2015.52","article-title":"Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients","volume":"20","author":"J Frank","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"8","key":"pone.0340584.ref044","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1038\/s41380-019-0575-1","article-title":"Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study","volume":"26","author":"K Kowalec","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"5","key":"pone.0340584.ref045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1192\/bjp.2019.120","article-title":"Clinical indicators of treatment-resistant psychosis","volume":"216","author":"SE Legge","year":"2020","journal-title":"Br J Psychiatry"},{"issue":"5","key":"pone.0340584.ref046","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/schbul\/sbx007","article-title":"Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia","volume":"43","author":"T Wimberley","year":"2017","journal-title":"Schizophr Bull"},{"issue":"1","key":"pone.0340584.ref047","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1176\/appi.ajp.2018.17121363","article-title":"Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis","volume":"176","author":"J-P Zhang","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"9","key":"pone.0340584.ref048","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41591-021-01475-7","article-title":"Prognostic value of polygenic risk scores for adults with psychosis","volume":"27","author":"I Landi","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"pone.0340584.ref049","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ng.3755","article-title":"Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn\u2019s disease","volume":"49","author":"JC Lee","year":"2017","journal-title":"Nat Genet"},{"issue":"3","key":"pone.0340584.ref050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.25530","article-title":"Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition","volume":"86","author":"G Leonenko","year":"2019","journal-title":"Ann Neurol"},{"issue":"6","key":"pone.0340584.ref051","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41588-021-00847-6","article-title":"Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson\u2019s disease","volume":"53","author":"G Liu","year":"2021","journal-title":"Nat Genet"},{"key":"pone.0340584.ref052","doi-asserted-by":"crossref","first-page":"570928","DOI":"10.3389\/fpsyg.2020.570928","article-title":"Love and Romantic Relationships in the Voices of Patients Who Experience Psychosis: An Interpretive Phenomenological Analysis","volume":"11","author":"MD Budziszewska","year":"2020","journal-title":"Front Psychol"},{"key":"pone.0340584.ref053","article-title":"Interrelationships of changes in outcome domains in patients with schizophrenia spectrum disorders: a meta-analysis","author":"L de Winter","year":"2025","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"pone.0340584.ref054","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1176\/appi.ps.202000888","article-title":"Developing an International Standard Set of Patient-Reported Outcome Measures for Psychotic Disorders","volume":"73","author":"E McKenzie","year":"2022","journal-title":"Psychiatr Serv"},{"issue":"11","key":"pone.0340584.ref055","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-088266","article-title":"Identifying priorities for future research on reducing and stopping psychiatric medication: results of a James Lind Alliance priority-setting partnership","volume":"14","author":"M Boland","year":"2024","journal-title":"BMJ Open"},{"issue":"4","key":"pone.0340584.ref056","article-title":"Views of individuals diagnosed with schizophrenia on working life: A qualitative study","volume":"12","author":"Z\u00c7 Duman","year":"2021","journal-title":"Journal of Psychiatric Nursing\/Psikiyatri Hemsireleri Dernegi"},{"key":"pone.0340584.ref057","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40900-016-0054-7","article-title":"Priority setting in research: user led mental health research","volume":"3","author":"M Ghisoni","year":"2017","journal-title":"Res Involv Engagem"},{"key":"pone.0340584.ref058","article-title":"Genomics of schizophrenia, bipolar disorder and major depressive disorder","author":"MJ Owen","year":"2025","journal-title":"Nat Rev Genet"},{"issue":"12","key":"pone.0340584.ref059","article-title":"Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval","volume":"15","author":"EA King","year":"2019","journal-title":"PLoS Genet"},{"issue":"8012","key":"pone.0340584.ref060","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-024-07316-0","article-title":"Refining the impact of genetic evidence on clinical success","volume":"629","author":"EV Minikel","year":"2024","journal-title":"Nature"},{"issue":"10","key":"pone.0340584.ref061","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006944","article-title":"Genetic epidemiology and Mendelian randomization for informing disease therapeutics: Conceptual and methodological challenges","volume":"13","author":"L Paternoster","year":"2017","journal-title":"PLoS Genet"},{"issue":"7","key":"pone.0340584.ref062","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.cell.2018.05.051","article-title":"Common Disease Is More Complex Than Implied by the Core Gene Omnigenic Model","volume":"173","author":"NR Wray","year":"2018","journal-title":"Cell"},{"issue":"1","key":"pone.0340584.ref063","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1017\/S0033291719002083","article-title":"Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies","volume":"51","author":"SE Smart","year":"2021","journal-title":"Psychol Med"},{"key":"pone.0340584.ref064","first-page":"40","article-title":"Assessing the Trajectory of Schizophrenia Effectively in Order to Treat Effectively","volume":"36","author":"M Agius","year":"2024","journal-title":"Psychiatr Danub"},{"issue":"3","key":"pone.0340584.ref065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/wps.20446","article-title":"Improving outcomes of first-episode psychosis: an overview","volume":"16","author":"P Fusar-Poli","year":"2017","journal-title":"World Psychiatry"},{"issue":"1","key":"pone.0340584.ref066","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s10038-020-00845-2","article-title":"Unique roles of rare variants in the genetics of complex diseases in humans","volume":"66","author":"Y Momozawa","year":"2021","journal-title":"J Hum Genet"},{"issue":"9","key":"pone.0340584.ref067","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41588-022-01064-5","article-title":"A phenotypic spectrum of autism is attributable to the combined effects of rare variants, polygenic risk and sex","volume":"54","author":"D Antaki","year":"2022","journal-title":"Nat Genet"},{"issue":"3","key":"pone.0340584.ref068","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.12.036","article-title":"Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism","volume":"180","author":"FK Satterstrom","year":"2020","journal-title":"Cell"},{"issue":"7487","key":"pone.0340584.ref069","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature12929","article-title":"De novo mutations in schizophrenia implicate synaptic networks","volume":"506","author":"M Fromer","year":"2014","journal-title":"Nature"},{"issue":"1","key":"pone.0340584.ref070","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1038\/s41467-021-25532-4","article-title":"Schizophrenia, autism spectrum disorders and developmental disorders share specific disruptive coding mutations","volume":"12","author":"E Rees","year":"2021","journal-title":"Nat Commun"},{"issue":"9","key":"pone.0340584.ref071","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamapsychiatry.2016.1831","article-title":"Analysis of Intellectual Disability Copy Number Variants for Association With Schizophrenia","volume":"73","author":"E Rees","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"pone.0340584.ref072","article-title":"GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research","volume":"358","author":"S Staniszewska","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"pone.0340584.ref073","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41537-024-00526-5","article-title":"Assessing the validity of a self-reported clinical diagnosis of schizophrenia","volume":"10","author":"GE Woolway","year":"2024","journal-title":"Schizophrenia (Heidelb)"},{"issue":"5","key":"pone.0340584.ref074","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/schbul\/sbab036","article-title":"Risk Factors, Clinical Features, and Polygenic Risk Scores in Schizophrenia and Schizoaffective Disorder Depressive-Type","volume":"47","author":"CA Dennison","year":"2021","journal-title":"Schizophr Bull"},{"key":"pone.0340584.ref075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/CLEP.S129779","article-title":"Clinical epidemiology in the era of big data: new opportunities, familiar challenges","volume":"9","author":"V Ehrenstein","year":"2017","journal-title":"Clin Epidemiol"},{"key":"pone.0340584.ref076","unstructured":"UK Research and Innovation. Draft UKRI research data policy. 2025."},{"key":"pone.0340584.ref077","unstructured":"Regulation (EU) 2025\/327 of the European Parliament and of the Council of 11 February 2025 on the European Health Data Space and amending Directive 2011\/24\/EU and Regulation (EU) 2024\/2847."},{"issue":"1","key":"pone.0340584.ref078","first-page":"1189","article-title":"Data Extraction and Management in Networks of Observational Health Care Databases for Scientific Research: A Comparison of EU-ADR, OMOP, Mini-Sentinel and MATRICE Strategies","volume":"4","author":"R Gini","year":"2016","journal-title":"EGEMS (Wash DC)"},{"issue":"1","key":"pone.0340584.ref079","first-page":"103","article-title":"Maelstrom Research guidelines for rigorous retrospective data harmonization","volume":"46","author":"I Fortier","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"1","key":"pone.0340584.ref080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12874-021-01252-7","article-title":"Facilitating harmonized data quality assessments. A data quality framework for observational health research data collections with software implementations in R","volume":"21","author":"CO Schmidt","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"pone.0340584.ref081","article-title":"Evolution of outcome measures in schizophrenia","volume":"50","author":"T Burns","year":"2007","journal-title":"Br J Psychiatry Suppl"},{"issue":"3","key":"pone.0340584.ref082","article-title":"Harmonization-Information Trade-Offs for Sharing Individual Participant Data in Biomedicine","volume":"4","author":"A Torres-Esp\u00edn","year":"2022","journal-title":"Harv Data Sci Rev"},{"key":"pone.0340584.ref083","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.schres.2022.08.016","article-title":"Revisiting the latent structure of negative symptoms in schizophrenia: Evidence from two second-generation clinical assessments","volume":"248","author":"S-B Li","year":"2022","journal-title":"Schizophr Res"},{"issue":"5","key":"pone.0340584.ref084","first-page":"433","article-title":"Beyond Lumping and Splitting: A Review of Computational Approaches for Stratifying Psychiatric Disorders","volume":"1","author":"AF Marquand","year":"2016","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"5","key":"pone.0340584.ref085","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/s41380-022-01500-2","article-title":"The impact of educational attainment, intelligence and intellectual disability on schizophrenia: a Swedish population-based register and genetic study","volume":"27","author":"J Song","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"1","key":"pone.0340584.ref086","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng.3725","article-title":"Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects","volume":"49","author":"CR Marshall","year":"2017","journal-title":"Nat Genet"},{"issue":"3","key":"pone.0340584.ref087","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41588-021-00997-7","article-title":"Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence data","volume":"54","author":"TOPMed Anthropometry Working Group, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium","year":"2022","journal-title":"Nat Genet"},{"issue":"6","key":"pone.0340584.ref088","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41436-018-0337-5","article-title":"Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions","volume":"21","author":"S Reisberg","year":"2019","journal-title":"Genet Med"},{"key":"pone.0340584.ref089","first-page":"1","article-title":"Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical Implications","volume":"5","author":"K Yoshida","year":"2020","journal-title":"Mol Neuropsychiatry"},{"issue":"1","key":"pone.0340584.ref090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41398-020-01129-1","article-title":"Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19","volume":"11","author":"AB Koopmans","year":"2021","journal-title":"Transl Psychiatry"},{"key":"pone.0340584.ref091","doi-asserted-by":"crossref","first-page":"711943","DOI":"10.3389\/fgene.2021.711943","article-title":"CYP3A4(*)22 Genotyping in Clinical Practice: Ready for Implementation?","volume":"12","author":"TAM Mulder","year":"2021","journal-title":"Front Genet"},{"issue":"7","key":"pone.0340584.ref092","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.bcp.2008.07.024","article-title":"Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers","volume":"76","author":"JE Muscat","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"pone.0340584.ref093","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.226","article-title":"PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge","volume":"1","author":"L Gong","year":"2021","journal-title":"Curr Protoc"},{"issue":"24","key":"pone.0340584.ref094","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1016\/j.neuron.2021.09.011","article-title":"Pharmacogenomics: A road ahead for precision medicine in psychiatry","volume":"109","author":"AF Pardi\u00f1as","year":"2021","journal-title":"Neuron"},{"issue":"3","key":"pone.0340584.ref095","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41431-023-01347-3","article-title":"Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics","volume":"32","author":"L Beunk","year":"2024","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"pone.0340584.ref096","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41380-018-0335-7","article-title":"A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropenia","volume":"24","author":"SE Legge","year":"2019","journal-title":"Mol Psychiatry"},{"key":"pone.0340584.ref097","unstructured":"Royal College of Psychiatrists. College Report CR237\u2013 The role of genetic testing in mental health settings. 2023."},{"issue":"7993","key":"pone.0340584.ref098","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"S Chen","year":"2024","journal-title":"Nature"},{"key":"pone.0340584.ref099","first-page":"148353","article-title":"Regional missense constraint improves variant deleteriousness prediction","author":"KE Samocha","year":"2017","journal-title":"bioRxiv"},{"issue":"3","key":"pone.0340584.ref100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"M Kircher","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"pone.0340584.ref101","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1176\/appi.ajp.2018.17040467","article-title":"Joint Contributions of Rare Copy Number Variants and Common SNPs to Risk for Schizophrenia","volume":"176","author":"CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"1","key":"pone.0340584.ref102","doi-asserted-by":"crossref","first-page":"21502","DOI":"10.1038\/s41598-022-26181-3","article-title":"Comparison of calling pipelines for whole genome sequencing: an empirical study demonstrating the importance of mapping and alignment","volume":"12","author":"RO Betschart","year":"2022","journal-title":"Sci Rep"},{"issue":"9","key":"pone.0340584.ref103","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41588-022-01104-0","article-title":"Rare coding variation provides insight into the genetic architecture and phenotypic context of autism","volume":"54","author":"JM Fu","year":"2022","journal-title":"Nat Genet"},{"key":"pone.0340584.ref104","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58615","article-title":"GWAS of three molecular traits highlights core genes and pathways alongside a highly polygenic background","volume":"10","author":"N Sinnott-Armstrong","year":"2021","journal-title":"Elife"},{"issue":"3","key":"pone.0340584.ref105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41588-018-0059-2","article-title":"Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection","volume":"50","author":"AF Pardi\u00f1as","year":"2018","journal-title":"Nat Genet"},{"issue":"18","key":"pone.0340584.ref106","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease","volume":"376","author":"MS Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0340584.ref107","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/mp.2013.156","article-title":"Evidence that duplications of 22q11.2 protect against schizophrenia","volume":"19","author":"E Rees","year":"2014","journal-title":"Mol Psychiatry"},{"issue":"10","key":"pone.0340584.ref108","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jamapsychiatry.2024.1453","article-title":"Population-Based Risk of Psychiatric Disorders Associated With Recurrent Copy Number Variants","volume":"81","author":"M Vaez","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"pone.0340584.ref109","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41467-021-21330-0","article-title":"Machine learning identifies candidates for drug repurposing in Alzheimer\u2019s disease","volume":"12","author":"S Rodriguez","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"pone.0340584.ref110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"A Subramanian","year":"2017","journal-title":"Cell"},{"key":"pone.0340584.ref111","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1038\/ncomms10331","article-title":"Network-based in silico drug efficacy screening","volume":"7","author":"E Guney","year":"2016","journal-title":"Nat Commun"},{"key":"pone.0340584.ref112","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac1046","article-title":"The next-generation Open Targets Platform: reimagined, redesigned, rebuilt","volume":"51","author":"D Ochoa","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"pone.0340584.ref113","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"GS Collins","year":"2024","journal-title":"BMJ"},{"issue":"1","key":"pone.0340584.ref114","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/jamapsychiatry.2017.3485","article-title":"Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder","volume":"75","author":"J Allardyce","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"pone.0340584.ref115","first-page":"336","article-title":"The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia","volume":"46","author":"AL Richards","year":"2020","journal-title":"Schizophr Bull"},{"issue":"3","key":"pone.0340584.ref116","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamapsychiatry.2018.3338","article-title":"Characterizing Developmental Trajectories and the Role of Neuropsychiatric Genetic Risk Variants in Early-Onset Depression","volume":"76","author":"F Rice","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"pone.0340584.ref117","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.biopsych.2016.06.028","article-title":"An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis","volume":"81","author":"E Vassos","year":"2017","journal-title":"Biol Psychiatry"},{"issue":"1","key":"pone.0340584.ref118","first-page":"65","article-title":"Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study","volume":"75","author":"International Consortium on Lithium Genetics (ConLi+Gen)","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"pone.0340584.ref119","doi-asserted-by":"crossref","first-page":"110170","DOI":"10.1016\/j.pnpbp.2020.110170","article-title":"Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder","volume":"108","author":"G Fanelli","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"pone.0340584.ref120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bpsgos.2021.07.008","article-title":"Identifying the Common Genetic Basis of Antidepressant Response","volume":"2","author":"O Pain","year":"2022","journal-title":"Biol Psychiatry Glob Open Sci"},{"issue":"11","key":"pone.0340584.ref121","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/nm.4196","article-title":"The implications of the shared genetics of psychiatric disorders","volume":"22","author":"MC O\u2019Donovan","year":"2016","journal-title":"Nat Med"},{"issue":"10","key":"pone.0340584.ref122","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/jamapsychiatry.2022.2594","article-title":"Genetic liabilities differentiating bipolar disorder, schizophrenia, and major depressive disorder, and phenotypic heterogeneity in bipolar disorder","volume":"79","author":"AL Richards","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"pone.0340584.ref123","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/s41467-017-02769-6","article-title":"Improving genetic prediction by leveraging genetic correlations among human diseases and traits","volume":"9","author":"RM Maier","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"pone.0340584.ref124","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/mp.2017.163","article-title":"Multi-polygenic score approach to trait prediction","volume":"23","author":"E Krapohl","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"2","key":"pone.0340584.ref125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S0033291716001355","article-title":"Mental disorders of known aetiology and precision medicine in psychiatry: a promising but neglected alliance","volume":"47","author":"D Fraguas","year":"2017","journal-title":"Psychol Med"},{"issue":"11","key":"pone.0340584.ref126","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41588-022-01200-1","article-title":"A combined polygenic score of 21,293 rare and 22 common variants improves diabetes diagnosis based on hemoglobin A1C levels","volume":"54","author":"AMP-T2D-GENES Consortium","year":"2022","journal-title":"Nat Genet"},{"issue":"8","key":"pone.0340584.ref127","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/mp.2015.143","article-title":"Common alleles contribute to schizophrenia in CNV carriers","volume":"21","author":"KE Tansey","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"1","key":"pone.0340584.ref128","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1038\/s41467-022-34163-2","article-title":"The contribution of common and rare genetic variants to variation in metabolic traits in 288,137 East Asians","volume":"13","author":"YJ Kim","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"pone.0340584.ref129","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13195-021-00884-7","article-title":"Probability of Alzheimer\u2019s disease based on common and rare genetic variants","volume":"13","author":"V Escott-Price","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"pone.0340584.ref130","article-title":"The Role of SLC39A8.p.(Ala391Thr) in Schizophrenia Symptom Severity and Cognitive Ability: Cross-Sectional Studies of Schizophrenia and the General UK Population","author":"SE Smart","year":"2025","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"2","key":"pone.0340584.ref131","doi-asserted-by":"crossref","first-page":"010318","DOI":"10.7189\/jogh.09.020318","article-title":"Artificial intelligence and algorithmic bias: implications for health systems","volume":"9","author":"T Panch","year":"2019","journal-title":"J Glob Health"},{"key":"pone.0340584.ref132","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41073-016-0007-6","article-title":"Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use","volume":"1","author":"S Heidari","year":"2016","journal-title":"Res Integr Peer Rev"},{"issue":"21","key":"pone.0340584.ref133","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1111\/bph.14584","article-title":"Sex differences in schizophrenia, bipolar disorder, and post-traumatic stress disorder: Are gonadal hormones the link?","volume":"176","author":"A Gogos","year":"2019","journal-title":"Br J Pharmacol"},{"issue":"1","key":"pone.0340584.ref134","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00737-023-01371-8","article-title":"Sex differences in schizophrenia-spectrum diagnoses: results from a 30-year health record registry","volume":"27","author":"M Ferrara","year":"2024","journal-title":"Arch Womens Ment Health"},{"issue":"1","key":"pone.0340584.ref135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41537-020-00120-5","article-title":"Understanding sex differences in long-term outcomes after a first episode of psychosis","volume":"6","author":"R Ayesa-Arriola","year":"2020","journal-title":"NPJ Schizophr"},{"issue":"10468","key":"pone.0340584.ref136","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/S0140-6736(24)02469-3","article-title":"Scientific consideration of sex and gender is the responsibility of the many, not the few","volume":"404","author":"A Witt","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"pone.0340584.ref137","article-title":"Post-GWAS in Psychiatric Genetics: A Developmental Perspective on the \u201cOther\u201d Next Steps","volume":"17","author":"DM Dick","year":"2018","journal-title":"Genes Brain Behav"},{"issue":"1","key":"pone.0340584.ref138","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41398-021-01649-4","article-title":"Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individuals","volume":"11","author":"E Koch","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"9","key":"pone.0340584.ref139","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11090929","article-title":"Stratification by sex and hormone level when contrasting men and women in schizophrenia trials will improve personalized treatment","volume":"11","author":"MV Seeman","year":"2021","journal-title":"J Pers Med"},{"key":"pone.0340584.ref140","unstructured":"Medical Science Sex and Gender Equity. Accounting for sex and gender in biomedical, health and care research: A policy framework for research funders. 2025. Available from: https:\/\/www.messageproject.co.uk\/"},{"issue":"10","key":"pone.0340584.ref141","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.cell.2022.04.012","article-title":"Precision medicine requires understanding how both sex and gender influence health","volume":"185","author":"NS Stachenfeld","year":"2022","journal-title":"Cell"},{"issue":"3","key":"pone.0340584.ref142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003348","article-title":"Power and predictive accuracy of polygenic risk scores","volume":"9","author":"F Dudbridge","year":"2013","journal-title":"PLoS Genet"},{"issue":"6","key":"pone.0340584.ref143","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2215-0366(25)00061-6","article-title":"Recommendations for defining treatment outcomes in major psychiatric disorders using real-world data","volume":"12","author":"E Koch","year":"2025","journal-title":"Lancet Psychiatry"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0340584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:36:22Z","timestamp":1770316582000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0340584"}},"subtitle":[],"editor":[{"given":"Avanti","family":"Dey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":143,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0340584","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}